Iovance Biotherapeutics Inc. (IOVA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Iovance Biotherapeutics I...

    NASDAQ: IOVA · Real-Time Price · USD
    2.11
    0.09 (4.46%)
    At close: Sep 26, 2025, 3:59 PM
    2.09
    -0.95%
    After-hours: Sep 26, 2025, 07:55 PM EDT

    Iovance Biotherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 115.69M 114.89M 231.73M 78.23M
    Short-Term Investments
    		 208.09M 164.98M 240.11M 426.18M
    Long-Term Investments
    		 n/a 66.43M 6.43M 91.59M
    Other Long-Term Assets
    		 6.73M 270K -178.25M 7.87M
    Receivables
    		 69.34M 151K n/a n/a
    Inventory
    		 51.52M 10.37M n/a n/a
    Other Current Assets
    		 12.38M 17.46M 7.27M n/a
    Total Current Assets
    		 457.02M 307.85M 479.12M 507.96M
    Property-Plant & Equipment
    		 164.28M 176.54M 178.25M 169.92M
    Goodwill & Intangibles
    		 282.4M 229.26M n/a n/a
    Total Long-Term Assets
    		 453.41M 472.5M 6.43M 269.38M
    Total Assets
    		 910.43M 780.35M 663.98M 777.33M
    Account Payables
    		 27.51M 33.12M 26.6M 27.38M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 12.9M 7.78M 12.59M 5.06M
    Other Current Liabilities
    		 69.04M 26.82M 20.3M 30.2M
    Total Current Liabilities
    		 122.34M 110.31M 91.48M 89.2M
    Long-Term Debt
    		 1M 1M 1M 1M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 77.68M 85.43M 72.86M 66.47M
    Total Liabilities
    		 200.02M 195.74M 164.34M 155.67M
    Total Debt
    		 58.26M 75.86M 85.45M 71.53M
    Book Value
    		 710.4M 584.61M 499.64M 621.66M
    Book Value Per Share
    		 2.45 2.49 3.14 4.05
    Common Stock
    		 13K 11K 8K 7K
    Retained Earnings
    		 -2.38B -2.01B -1.57B -1.17B
    Comprehensive Income
    		 -1.05M 2.53M -902K -601K
    Shareholders Equity
    		 710.4M 584.61M 499.64M 621.66M
    Total Investments
    		 208.09M 164.98M 240.11M 517.77M

    Add to Watchlist